Kent Manson is the founder of Diasome Pharmaceuticals. Diasome Pharmaceuticals has raised $90M in total funding. Latest round: Series C.
Kent Manson is the Co-Founder and CEO of Diasome Pharmaceuticals, a clinical-stage biopharmaceutical company focused on therapies for diabetes, obesity, and metabolic disorders. He has successfully guided the company through multiple funding rounds, including a Series C financing with Eli Lilly and Company.
Full founder directory · Investor directory · Company funding database · Fundraising library